risperidone has been researched along with Metaplasia in 1 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Metaplasia: A condition in which there is a change of one adult cell type to another similar adult cell type.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We present the case of a 55-year-old patient with schizophrenia, who developed a skin eruption 5 weeks after initiating treatment with olanzapine." | 7.78 | Olanzapine-induced eccrine squamous syringometaplasia. ( Barabash, R; Molina-Ruiz, AM; Molina-Ruiz, RM; Requena, L; Zulueta, T, 2012) |
| " We present the case of a 55-year-old patient with schizophrenia, who developed a skin eruption 5 weeks after initiating treatment with olanzapine." | 3.78 | Olanzapine-induced eccrine squamous syringometaplasia. ( Barabash, R; Molina-Ruiz, AM; Molina-Ruiz, RM; Requena, L; Zulueta, T, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Molina-Ruiz, AM | 1 |
| Molina-Ruiz, RM | 1 |
| Zulueta, T | 1 |
| Barabash, R | 1 |
| Requena, L | 1 |
1 other study available for risperidone and Metaplasia
| Article | Year |
|---|---|
Olanzapine-induced eccrine squamous syringometaplasia.
Topics: Antipsychotic Agents; Benzodiazepines; Biopsy; Dermatologic Agents; Drug Substitution; Eccrine Gland | 2012 |